Jim’s current faves include three tech names and a bank stock. Read More: Here’s a rapid-fire update on our 33-stock portfolio, including Cramer’s 6
Stocks kicked off September on shaky footing as higher oil prices and Treasury yields tested investors’ appetite for some of the market’s biggest artificial intelligence winners.…
CNBC’s Jim Cramer said Monday that investors shouldn’t fear the latest market rotation. Instead, he thinks it’s creating buying opportunities in several high-quality stocks that have…
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires…
Stocks bounced back Friday, but not enough to recover the week’s earlier losses. All three major averages posted gains — with the Dow Jones Industrial Average…
Kenvue Inc. Tylenol brand pain reliever for sale at a pharmacy in New York, US, on Wednesday, March 27, 2024. Bloomberg | Bloomberg | Getty ImagesShares…
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1.…
Cold and flu medicine including NyQuil sit on a store shelf in Miami on Sept. 12, 2023.Joe Raedle | Getty ImagesCVS is removing some of the…
Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year guidance as sales in the company’s pharmaceutical…